Nimrod David Rico Martinez

Advanced reconstruction has become an essential component of modern oncologic care, particularly for patients undergoing mastectomy for breast cancer and those requiring reconstruction following skin cancer excision. The objective of this review was to analyze contemporary evidence regarding reconstructive strategies, clinical outcomes, patient-centered benefits, and emerging innovations in reconstructive oncology. A narrative and integrative literature review was conducted using scientific publications retrieved from major biomedical databases, including PubMed, Scopus, ScienceDirect, Web of Science, and Google Scholar. The reviewed evidence demonstrated that implant-based reconstruction, autologous tissue reconstruction, microsurgical procedures, local flaps, skin grafting techniques, and acellular dermal matrix-assisted approaches constitute the principal reconstructive modalities currently employed in oncologic practice. Implant-based reconstruction remains the most widely utilized option, whereas autologous and microsurgical techniques frequently provide superior long-term aesthetic and functional outcomes. In dermatologic oncology, local flap reconstruction continues to represent a highly effective solution for restoring complex anatomical regions while preserving function and cosmetic appearance. Patient-centered outcomes, including quality of life, body image, emotional well-being, social reintegration, and long-term satisfaction, were consistently identified as important indicators of reconstructive success. The findings also highlight the growing importance of multidisciplinary collaboration and individualized treatment planning in optimizing outcomes. Emerging technologies such as regenerative medicine, tissue engineering, bioengineered scaffolds, three-dimensional surgical planning, and artificial intelligence-assisted decision-making may further enhance reconstructive precision and patient care in the future. Overall, advanced reconstruction plays a critical role in improving functional recovery, aesthetic restoration, psychosocial adaptation, and survivorship among patients affected by breast cancer and cutaneous malignancies.

Precision medicine has progressively transformed anesthesiology by promoting individualized perioperative management based on biological, physiological, and technological information. Within this context, biomarker-guided anesthesia and real-time metabolic monitoring have emerged as promising approaches for improving patient safety, optimizing anesthetic interventions, and enhancing clinical outcomes in surgical and critically ill populations. This review analyzed current scientific evidence regarding the role of biomarkers, advanced physiological monitoring technologies, pharmacogenomics, artificial intelligence, and metabolic surveillance systems in precision anesthesia. A comprehensive review of the literature published between 2009 and 2025 was conducted using major biomedical databases, including PubMed/MEDLINE, Scopus, Web of Science, ScienceDirect, SpringerLink, Wiley Online Library, and the Cochrane Library. The findings demonstrated increasing utilization of cardiovascular and metabolic biomarkers, electroencephalographic monitoring, near-infrared spectroscopy, continuous glucose monitoring, lactate surveillance, advanced hemodynamic assessment, and artificial intelligence-supported decision systems. Collectively, these technologies contributed to improved risk stratification, earlier detection of physiological deterioration, optimization of anesthetic drug administration, enhanced postoperative recovery, and reduction of perioperative complications. The evidence also indicated that multimodal monitoring strategies consistently outperform isolated monitoring approaches by providing a more comprehensive representation of patient physiology. Furthermore, artificial intelligence and automated monitoring platforms showed significant potential for improving predictive accuracy and individualized clinical decision-making. Overall, biomarker-guided precision anesthesia and real-time metabolic monitoring represent transformative developments in perioperative and critical care medicine. The integration of biological indicators, advanced monitoring technologies, and data-driven clinical strategies supports a more personalized approach to anesthetic management and may contribute to safer, more effective, and outcome-oriented patient care. Continued research and technological standardization will be essential to facilitate broader implementation of precision anesthesia within future healthcare systems.

Electronic cigarettes have gained popularity worldwide, particularly among adolescents and young adults, raising serious concerns regarding their pulmonary health impacts. In Latin America, where regulatory responses differ across countries, Mexico, Colombia, and Ecuador provide a valuable context to examine vaping behaviors, respiratory risks, and policy frameworks. This study evaluated prevalence, usage patterns, respiratory outcomes, risk perceptions, and device preferences through a cross-sectional design with stratified random sampling of 3,000 participants (Mexico: 1,200; Colombia: 1,000; Ecuador: 800). Data were collected through validated questionnaires and complemented with secondary sources from WHO, PAHO, and national health surveys. Results showed that e-cigarette use was most frequent in individuals aged 15–24 years, with Mexico reporting the highest prevalence (28%), followed by Colombia (24%) and Ecuador (18%). Users reported higher rates of cough (42% vs. 15%), wheezing (28% vs. 9%), and dyspnea (35% vs. 12%), as well as increased medical consultations (30% vs. 10%) and hospitalizations (12% vs. 3%) compared with non-users. Misperceptions of reduced harm were more common among participants with lower education, while pods and disposables dominated device preferences, often with medium-to-high nicotine concentrations. These findings confirm the association of vaping with respiratory morbidity, misperceptions of safety, and rising dependence on high-nicotine devices. Pulmonologists and policymakers in Latin America must prioritize prevention, accurate risk communication, and enforcement of comprehensive regulations to protect vulnerable populations, especially adolescents and young adults, from the long-term burden of vaping-related lung disease.